Physician profile
Loan-Thy Dang
NPI 1891923108
$3,480.92
in general payments reported to CMS, 2019-2025
36 companies · $39.53 in 2025
The $39.53 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,680 · 2020: $474 · 2021: $1,273 · 2023: $15.09 · 2025: $39.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $419.94 | 2019-2021 | |
| Gilead Sciences, INC. | $410.77 | 2019-2021 | |
| Novo Nordisk INC | $339.97 | 2019-2021 | |
| Amgen INC. | $284.64 | 2019-2025 | Evenity, Prolia |
| Abbvie INC. | $262.00 | 2019-2021 | |
| Amarin Pharma, INC. | $246.26 | 2019-2021 | |
| Glaxosmithkline, LLC. | $204.21 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $202.91 | 2019-2021 | |
| Lilly USA, LLC | $122.45 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.34 | 2021 | |
| Novartis Pharmaceuticals Corporation | $95.82 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $69.12 | 2019-2020 | |
| Esperion Therapeutics, INC. | $67.07 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $59.04 | 2019-2021 | |
| Pfizer INC. | $57.33 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $52.66 | 2020-2021 | |
| Dynavax Technologies Corporation | $49.36 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.86 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $33.98 | 2019 | |
| Sanofi Pasteur INC. | $32.36 | 2019 | |
| Allergan, INC. | $30.71 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $30.36 | 2021 | |
| Hologic Sales and Service, LLC | $30.20 | 2019 | |
| Corcept Therapeutics | $24.97 | 2021 | |
| Genentech USA, INC. | $23.57 | 2020 | |
| Abbott Laboratories | $20.85 | 2021 | |
| Dexcom, INC. | $19.81 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.23 | 2020 | |
| Vivus LLC | $17.19 | 2021 | |
| Astellas Pharma US INC | $16.74 | 2021 | |
| Phadia US INC. | $14.93 | 2021 | |
| Althera Pharmaceuticals LLC | $14.50 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.00 | 2019 | |
| Mission Pharmacal Company | $13.80 | 2019 | |
| Optinose US, INC. | $13.71 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $12.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loan-Thy Dang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.